Venom-Derived Peptide
A peptide isolated from or inspired by animal venom (snakes, spiders, scorpions, cone snails, Gila monsters). Exenatide is derived from exendin-4, a peptide found in Gila monster saliva. Venom-derived peptides are a rich source of pharmacologically active molecules for drug development.
Technical Context
Animal venoms are rich sources of bioactive peptides optimised by millions of years of evolution for potency and selectivity. Approved venom-derived drugs: exenatide (from Gila monster Heloderma suspectum saliva — exendin-4 peptide, the first GLP-1 RA), ziconotide (from cone snail Conus magus — omega-conotoxin MVIIA, a voltage-gated calcium channel blocker for severe pain), eptifibatide (from pygmy rattlesnake Sistrurus miliarius — barbourin peptide derivative, platelet glycoprotein IIb/IIIa antagonist), and bivalirudin (inspired by hirudin from medicinal leech Hirudo medicinalis — direct thrombin inhibitor). Venom peptide research continues to yield drug candidates: spider venom peptides targeting ion channels, scorpion venom peptides for antimicrobial and anticancer applications, and additional cone snail conotoxins for pain management. The diversity of venom peptide targets and mechanisms makes venomics an active drug discovery field.